A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis

Ivan R. Schwab, M. Friedlaender, J. McCulley, S. J. Lichtenstein, C. T. Moran, Cono M. Grasso

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)150-151
Number of pages2
JournalEvidence-Based Eye Care
Volume4
Issue number3
DOIs
StatePublished - Jul 1 2003

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this